Motorcycle manufacturing is a tricky business. Sometimes the next big thing turns out to be the next big flop. But sometimes, a model becomes so successful it transcends a brand's reputation. These ...
Gilead and Novo Nordisk have announced their drug combinations for the fatty liver disease known as NASH checked out in a mid-stage proof-of-concept study. The companies said the trial met its primary ...
Interactive Chart for First Trust Industrials/Producer Durables AlphaDEX Fund (FXR), analyze all the data with a huge range of indicators.